Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05064280
Title Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

lung non-small cell carcinoma

triple-receptor negative breast cancer

Advanced Solid Tumor

Therapies

Lenvatinib

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST